To the Editor:
In young children unable to perform reliable and reproducible spirometry, non-cooperative lung function techniques are necessary to measure bronchial hyperreactivity (BHR) during bronchial challenge [1] . Measuring the decrease in transcutaneous partial pressure of oxygen (PtcO 2 ) is a robust technique that detects increased ventilation-perfusion mismatch during bronchial challenge [2] in preschool and school-aged children [3] [4] [5] , and a 20% decrease in PtcO 2 correlates to a 20% forced expiratory volume in 1 s (FEV1) decrease in children aged 6-14 years [3] and in adults (with correlation to arterial oxygen tension) [6] . When neither spirometry nor PtcO 2 is available, other BHR outcomes can be measured such as wheezing that appears for mean±SD decreases of −44.7±14.5% in FEV1 and −6.3±2.7% in transcutaneous saturation of oxygen (SpO 2 ) [7] . Respiratory resistances are easy to measure [8] [9] [10] but the relevant threshold for BHR is not yet defined and an at least 35% increase variably correlates with PtcO 2 changes [8, 11] . First, we aimed to better study two alternative outcomes (i.e. interrupter resistance (Rint) and SpO 2 ) and challenge the current recommendations [1] of measuring resistance during inspiration (as opposed to measuring during expiration for reversibility testing [12] ), because the physiological expiratory glottis closure can be enhanced during bronchial challenge-induced bronchoconstriction and specific extrathoracic airway reactivity to bronchoconstrictor agents can occur. Second, we wished to evaluate the proposed thresholds for Rint and SpO 2 (+35% and −5% baseline, respectively), as only a 3% decrease is considered to be significant in sleep studies and a mean±SD SpO 2 decrease of −5.2±3.1% corresponds to a much larger than 20% decrease in FEV1 in 5-8-year-old asthmatic children (−33.3±7.4% decrease in FEV1) [13] .
Between June 2013 and September 2014, we prospectively and consecutively included 28 children unable to correctly perform a spirometry who were referred to our lung function laboratory for a methacholine challenge. Children had to be free of treatment and acute respiratory symptoms for 3 weeks. Chest auscultation had to be normal.
At each step of the bronchial challenge, inspiratory and expiratory series of at least five correct interruptions (Rint insp and Rint exp , respectively) were performed in random order (but always in the same order with each specific child) using a MicroRint device (Micro Medical, Rochester, UK). PtcO 2 and SpO 2 were recorded throughout the test as previously described [8] using a Tina CombiM (Radiometer, Bronshoj, Denmark). Lung function was checked to be within the range of normal at baseline and assessed after inhalation of saline (diluent) to obtain the reference for changes during the challenge. Doubling doses of methacholine were inhaled, using the dosimeter method, every 5 min [8] , from 50 µg up to a cumulative dose of 800 µg. The test ended when PtcO 2 had fallen by 20% or more (PD20PtcO 2 ), the child had respiratory symptoms or the maximal dose of methacholine was reached. The study was approved by the Institutional Review Board of the French learned society for respiratory medicine (Société de Pneumologie de Langue Française) (CEPRO 2013-015) and the children's parents gave informed consent to the study.
Repeated measurements in children were compared using paired the Wilcoxon signed-rank test. Comparisons of lung function indices between groups of children (responsive and nonresponsive) were performed using the Fisher exact test. 27 (13 girls and 14 boys, median (range) age 5.5 (4.2-8.1) years) children completed all measurements during the bronchial challenge. One child pulled off the PtcO 2 electrode before the end of the test and was, therefore, excluded. 25 children were referred for chronic cough (started at a median age of 2.7 (0.3-8) years), one for suspicion of wheezing and one for dyspnoea upon exertion.
At baseline, Rint exp was higher than Rint insp (mean 0.81 versus 0.60 kPa·s·L ); p<0.0001), but within the range of normal for all children [14] . At the time of interruption, expiratory airflow was lower than inspiratory airflow throughout the test (e.g. at baseline: 0.30 and 0.39 L·s −1 , respectively; p<0.002). 20 children reached the PD20PtcO 2 at a median cumulative dose of methacholine of 100 µg (50-400 µg) (responsive children) without any respiratory symptoms. 14 responsive children had an at least 35% Rint insp increase (PD35Rint insp ) during the methacholine 
